MouSensor, Inc.

MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD.…

Read More

Ionica Sciences

Ionica Sciences is developing a spectroscopy-based diagnostic platform capable of targeting myriad infectious diseases, with Lyme disease serving as our initial focus and test case. Team: Omar Green – CEO,…

Read More

Lanyard Therapeutics

We are developing a first-in-class and best-in-class biologics for mechanism-based cancer immunotherapy Lanyard Theraputics Team: Ming Li Dr. Xiuyan Wang Douglas Zhang  

Read More

Super-Releaser, LLC

Our technologies leverage rapid prototyping, digitally fabricated molding, and parametric CAD to engineer active orthoses that function safely and seamlessly with the body’s kinematics. Super-Releaser, LLC Team: Matthew Borgatti Kari…

Read More

Chylos, Inc.

We have discovered a microRNA, miR-30c, which lowers plasma cholesterol and atherosclerosis in mice. We would like to commercialize it as a drug to treat hyperlipidemia and atherosclerosis. Chylos, Inc.…

Read More

RecoverLINK

RecoverLINK is a mobile health technology that transforms how heart failure patients experience care after hospital discharge. RecoverLINK Team: Christina Anzalone Laurie Thackeray  

Read More

Monogram Orthopaedics

I plan to design, patent, prototype, test and manufacture custom total joint replacement implants optimized for use with a surgical robot. Monogram Orthopaedics Team: Doug Unis

Read More

6Degrees

Crescent’, a revolutionary arm band, allows disabled individuals to operate any blue-tooth enabled device and re-integrate with the work force and social media‘Crescent’, a revolutionary arm band, allows disabled individuals…

Read More

Kures, inc.

I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression. Kures, Inc. Team: Andrew Kruegel

Read More